Cardiac Tolerability of Concurrent Administration of Trastuzumab and Anthracycline-Based Regimen as Adjuvant Chemotherapy for Breast Cancer

BACKGROUND: Retrospective analysis suggests that anthracycline-containing regimens may be superior to non-anthracycline-containing regimens in patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer. However, both trastuzumab and anthracycline have cardiotoxicity, and it...

Full description

Saved in:
Bibliographic Details
Main Authors: Watanabe, Naoki, Otsuka, Shoko, Sasaki, Yoko, Shimojima, Reiko, Wani, Yoji, Uchino, Kaori
Format: Artigo
Language:Inglês
Published: S. Karger GmbH 2014
Subjects:
Original Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3995382/
https://ncbi.nlm.nih.gov/pubmed/24803887
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000358754
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items